glp-1 multiple endocrine neoplasia GLP-1RA and thyroid cancer: New study suggests detection bias, not causation glp-1_analogs [TUSOM | Pharmwiki]

It improves fat metabolism by transporting fat to the cell mitochondria, where it is burned

While mild, occasional sweating during tirzepatide treatment may not require immediate medical attention, certain patterns and accompanying symptoms warrant prompt evaluation by a healthcare provider: Call 911 or go to the emergency department if sweating occurs with: Signs of severe hypoglycemia: confusion, severe shakiness, difficulty speaking, loss of consciousness, or seizures (requiring assistance from others) Chest pain, shortness of breath, or irregular heartbeat Severe abdominal pain, particularly if radiating to the back (potential pancreatitis) Signs of severe dehydration: decreased urination, extreme thirst, dizziness, or fainting Allergic reaction symptoms: rash, hives, facial swelling, or difficulty breathing Contact your doctor within 2448 hours if you experience: Persistent or worsening night sweats that disrupt sleep Sweating accompanied by fever, fatigue, or weight loss that is unexpected or outside your treatment plan Sweating episodes that consistently occur after meals or at specific times New-onset sweating that began after starting tirzepatide or increasing the dose Sweating severe enough to require frequent clothing changes or that interferes with daily activities Your healthcare provider will likely assess blood glucose patterns, review concurrent medications, evaluate hydration status, and consider whether dose adjustment is appropriate

Mov Disord Clin Pract 11(7):808813

Pregnancy and breastfeeding are the only female-specific contraindications

Although -synuclein is frequently implicated in PD pathogenesis, other proteins such as PTEN induced putative kinase 1 (PINK1), Parkin, DJ-1, leucine-rich repeat kinase 2 (LRRK2) have been strongly linked to familial forms of PD 6,7

These medications can also help improve metabolism